A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies.
Assessment
Damage
Idiopathic inflammatory myopathy
Magnetic resonance imaging
Myositis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
received:
22
04
2024
accepted:
08
06
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
aheadofprint
Résumé
Currently, standardized magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults are lacking. Therefore, we will perform a scoping review of the literature to collate and evaluate the existing semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs. The aim is to compile evidence-based information that will facilitate the future development of a universal standardized MRI scoring system for both research and clinical applications in IIM. A systematic search of electronic databases (PubMed, EMBASE, and Cochrane) will be undertaken to identify relevant articles published between January 2000 and October 2023. Data will be synthesized narratively. This scoping review seeks to comprehensively summarize and evaluate the evidence on the scanning protocols and scoring systems used in the assessment of diagnosis, disease activity, and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for the MRI assessment of skeletal muscle changes in patients with IIMs.
Identifiants
pubmed: 38976028
doi: 10.1007/s00296-024-05649-7
pii: 10.1007/s00296-024-05649-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIEHS NIH HHS
ID : ES101081
Pays : United States
Organisme : NIEHS NIH HHS
ID : ES101081
Pays : United States
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O’Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, UK and Ireland) (2017) International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468
Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https://doi.org/10.1038/s41572-021-00321-x
doi: 10.1038/s41572-021-00321-x
pubmed: 34857798
Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O’, Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med 8(11):2013. https://doi.org/10.3390/jcm8112013
Zubair AS, Salam S, Dimachkie MM, Machado PM, Bhaskar R (2023) Imaging biomarkers in the idiopathic inflammatory myopathies. Front Neurol 14:1146015. https://doi.org/10.3389/fneur.2023.1146015
doi: 10.3389/fneur.2023.1146015
pubmed: 37181575
pmcid: 10166883
Theodorou DJ, Theodorou SJ, Kakitsubata Y (2012) Skeletal muscle disease: patterns of MRI appearances. Br J Radiol 85(1020):e1298–1308. https://doi.org/10.1259/bjr/14063641
doi: 10.1259/bjr/14063641
pubmed: 22960244
pmcid: 3611737
Feinstein AR, Wells CK, Joyce CM, Josephy BR (1985) The evaluation of sensibility and the role of patient collaboration in clinimetric indexes. Trans Assoc Am Physicians 98:146–149
pubmed: 3916037
Hebert JS, Wolfe DL, Miller WC, Deathe AB, Devlin M, Pallaveshi L (2009) Outcome measures in amputation rehabilitation: ICF body functions. Disabil Rehabil 31(19):1541–1554. https://doi.org/10.1080/09638280802639467
doi: 10.1080/09638280802639467
pubmed: 19479495
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE (2018) PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 169(7):467–463. https://doi.org/10.7326/M18-0850
doi: 10.7326/M18-0850
pubmed: 30178033
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Part 1. N Engl J Med 292(7):344–347. https://doi.org/10.1056/NEJM197502132920706
doi: 10.1056/NEJM197502132920706
pubmed: 1090839
Chan MW, Leckie A, Xavier F, Uleryk E, Tadros S, Blanchette V, Doria AS (2013) A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia 19(6):e324–e334. https://doi.org/10.1111/hae.12248
doi: 10.1111/hae.12248
pubmed: 23919318
Tolsgaard MG, Ellaway R, Woods N, Norman G (2019) Salami-slicing and plagiarism: how should we respond? Adv Health Sci Educ Theory Pract 24(1):3–14. https://doi.org/10.1007/s10459-019-09876-7
doi: 10.1007/s10459-019-09876-7
pubmed: 30756257
Goyal NA, Mozaffar T, Dimackie MM (2023) Imaging beyond muscle resonance imaging in inclusion body myositis. Clin Exp Rheumatol 41(2):386–392. https://doi.org/10.55563/clinexprheumatol/uimkey
doi: 10.55563/clinexprheumatol/uimkey
pubmed: 36700664
Day J, Patel S, Limaye V (2017) The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. Semin Arthritis Rheum 46(5):642–649. https://doi.org/10.1016/j.semarthrit.2016.11.001
doi: 10.1016/j.semarthrit.2016.11.001
pubmed: 28088340